Device for treating inner ear disorders such as tinnitus or hearing loss
Patent Information
- Application Number
- HK62026126872
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-08-01
- Filing Date
- 2026-07-30
- Publication Date
- 2026-09-11
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480048074.4 (22) Application Date 2024.07.17 (30) Priority Data 23382805.2 2023.08.01 EP (85) PCT International Application Entering National Phase Date 2026.01.20 (86) PCT International Application Application Data PCT / ES2024 / 070459 2024.07.17 (87) PCT International Application Publication Data WO2025 / 027219 ES 2025.02.06 (71) Applicant JTG Solutions Ltd. Address Barcelona, Spain (72) Inventor G. Martinez-Monche Zaragoza (74) Patent Agency Yongxin Patent & Trademark Agency Ltd. 72002 Patent Attorney Wang Yongjian (51) Int.Cl. A61N 1 / 36 (2006.01) A61N 1 / 04 (2006.01) H04R 1 / 10 (2026.01) H04R 25 / 00 (2006.01) (54) Invention Title Device for Treating Inner Ear Diseases Such as Tinnitus or Hearing Loss (57) Abstract This invention relates to a device (1) for treating inner ear diseases such as tinnitus or hearing loss in a patient (100), the device comprising at least one electrode (5a, 5b) adapted to transmit an electrical stimulation signal (3) to the patient (100). The at least one electrode (5a, 5b) is mounted on a support (6) configured such that when the at least one electrode (5a, 5b) is placed on the patient (100), it is positioned on the anterior superior part of the mastoid process (101) of the patient (100), such that the electrical stimulation signal (3) transmitted from the at least one electrode (5a, 5b) can reach the anterior superior part of the mastoid process (101) of the patient (100).Claims 1 page, Description 8 pages, Drawings 8 pages, Claims amended according to Article 19 of the Treaty 1 page CN 121604991 A 2026.03.03 CN 1 21 60 49 91 A 1. A device (1) for treating an inner ear disease such as tinnitus or hearing loss in a patient (100), the device comprising at least one electrode (5a, 5b) adapted to transmit an electrical stimulation signal (3) to the patient (100), characterized in that the at least one electrode (5a, 5b) is mounted on a support (6) configured such that when the support is placed on the patient (100), the at least one electrode (5a, 5b) is arranged on the anterior superior portion of the mastoid process (101) of the patient (100), such that the electrical stimulation signal (3) transmitted from the at least one electrode (5a, 5b) reaches the anterior superior portion of the mastoid process (101) of the patient (100). 2. The device according to the preceding claim, wherein the dominant frequency component of the electrical stimulation signal (3) is greater than 200 kHz and less than 600 kHz. 3. The device according to the preceding claim, wherein the dominant frequency component of the electrical stimulation signal (3) is between 450 kHz and 540 kHz. 4. The device according to the preceding claim, wherein the dominant frequency component of the electrical stimulation signal (3) is 495 kHz. 5. The device according to any one of the preceding claims, wherein the device includes a first electrode (5a) and a second electrode (5b) mounted on the support (6), the support being configured such that when the electrodes (5a, 5b) are placed on the patient (100), they are positioned on the anterior superior portion of the mastoid process (101) of the patient (100). 6. The device (1) according to the preceding claim, characterized in that, in the direction where the distance between the first electrode (5a) and the second electrode (5b) is minimized, the spacing distance (d1) between the first electrode (5a) and the second electrode (5b) is less than the distance (d2) between the two ends of the first electrode (5a) and the distance (d2) between the two ends of the second electrode (5b). 7. The device (1) according to any one of claims 5 to 6, characterized in that the first electrode (5a) and the second electrode (5b) are of the same size. 8. The device (1) according to any one of claims 5 to 7, characterized in that the first electrode (5a) and the second electrode (5b) are symmetrically arranged on the support member (6). 9. The device (1) according to any one of claims 5 to 8, characterized in that the first electrode (5a) and the second electrode (5b) are arc-shaped.10. The device (1) according to any one of claims 5 to 9, characterized in that the first electrode (5a) and the second electrode (5b) are parallel to each other. 11. The device (1) according to any one of the preceding claims, characterized in that the support (6) comprises an earmuff (10) having a cross-section (C) defining a horseshoe arc, the earmuff (10) being adapted to be positioned to cover and surround the auricle (103) of the patient (100), and the at least one electrode (5a, 5b) being disposed at one end of the earmuff (10). 12. The device (1) according to any one of the preceding claims, characterized in that the device further comprises a sound-generating device (9). 13. The device (1) according to the preceding claim, characterized in that the sound-generating device (9) is adapted to emit sound having a blocking frequency band. 14. The device (1) according to the preceding claim, characterized in that the device comprises a processing device (11) adapted to block the frequency band of an audio signal (12). 15. The device (1) according to any one of the preceding claims, characterized in that the support (6) is an earphone (7). Claims 1 / 1 page 2 CN 121604991 A Device for Treating Inner Ear Disorders Such as Tinnitus or Hearing Loss Technical Field
[0001] The device for treating inner ear disorders of the present invention is a device capable of generating electrical stimulation suitable for treating hearing impairments such as tinnitus or hearing loss. Background Art
[0002] Hearing loss is divided into conductive hearing loss and sensorineural hearing loss. Conductive hearing loss often has mechanical factors because sound cannot be effectively conducted from the outer ear to the middle ear. Auditory discrimination ability is hardly affected, and most cases can be resolved by surgery or appropriate prescription amplification.
[0003] Sensorineural hearing loss, as a hearing impairment, often occurs when the inner ear or the neural pathway between the inner ear and the brain is damaged. This is the most common type of hearing loss and cannot be corrected by medication or surgery. Most cases can be resolved by appropriate prescription amplification.
[0004] The degree of hearing loss in a patient can be measured in a known manner using audiograms. An audiogram is a graph that shows the results of pure-tone audiometry, automated audiometry, or computed tomography, which are typically performed within a standardized frequency set. It shows the type, degree, and distribution of hearing loss.
[0005] Another type of sensorineural hearing loss is tinnitus, which manifests as a continuous pitch perceived by the patient in one or both ears.
[0006] To determine the frequency of tinnitus, broadband noise is introduced in a known manner, and the patient is asked to determine when their tinnitus disappears. Other tinnitus tests include residual inhibition tests, which record the duration for which sound diminishes or disappears in an individual's ear after a period of masking.
[0007] Currently, some devices are known to treat sensorineural hearing impairments such as tinnitus using electrical stimulation signals. However, the electrical stimulation signals in these devices are designed to generate currents that stimulate neurons and maintain the neuronal activation frequency, thus requiring the maintenance of a frequency that allows neurons to recover from stimulation. This means that low frequencies are needed to maintain this neuronal activation frequency.
[0008] The location of the electrical stimulation signal application within the patient's body is also important, as the electrical stimulation signal must be applied to a point near the neuron, and the placement of the device applying the electrical stimulation signal is crucial for achieving satisfactory therapeutic effects.
[0009] Some devices are known to apply electrical stimulation signals to the tongue. These devices are equipped with peripheral devices that the patient must place in their mouth to contact the tongue for the therapeutic effect to be achieved. Patent document EP2842530 discloses one such device. However, the use of these devices can cause discomfort to the patient.
[0010] Therefore, the object of the present invention is to disclose a device for treating hearing impairment that is simple in structure, easy to use, and has significant therapeutic effects.
[0011] The device of the present invention for treating inner ear diseases such as sensorineural inner ear disorders (e.g., tinnitus or hearing loss) includes at least one electrode adapted to transmit an electrical stimulation signal to a patient.
[0012] Essentially, the device is characterized in that the at least one electrode is mounted on a support, which, according to specification page 1 / 8 of CN 121604991 A, is configured such that when the at least one electrode is placed on a patient, it is positioned on the anterior superior portion of the patient's mastoid process, on the skin posterior to the insertion line of the auricle, such that the electrical stimulation signal transmitted from the at least one electrode can reach the anterior superior portion of the patient's mastoid process. Of course, contact with hair must be minimized, such that the one or more electrodes are positioned on the skin along the extension of an imaginary horizontal line passing through the external auditory canal. Given that the portion of the mastoid on which the one or more electrodes are placed is located posterior to the auricle, it is important that the device is capable of positioning the one or more electrodes on the skin posterior to the auricle and on the anterior end of the mastoid process near the external auditory canal. One or more electrodes are thus inserted away from the muscle insertion point of the sternocleidomastoid muscle. The device is intended to have two electrodes for conducting electrical stimulation signals between them, although only one electrode needs to be positioned on the anterosuperior part of the mastoid process, while the other electrode can be positioned elsewhere on the head. However, when both electrodes are mounted on the support and positioned on the anterosuperior part of the mastoid process, the energy of the electrical stimulation signal is concentrated on the anterosuperior part of the mastoid process, resulting in better efficacy. Of course, the alternating current electrical stimulation signal, without a direct current component, is conducted through the patient's skin between the electrodes, thereby diffusing the electrical stimulation signal through the skin to the designated area of the mastoid process.
[0013] In one embodiment variation, the dominant frequency component of the electrical stimulation signal is greater than 200 kHz and less than 600 kHz, preferably greater than 300 kHz, and the dominant frequency of the electrical stimulation signal is within the mid-frequency band specified in ITU-R Recommendation V.431-8 of August 8, 2015, for example, within the lower 10% of that mid-frequency band, i.e., between 300 kHz and 600 kHz. Advantageously, by means of the device subject of the present invention, an electrical stimulation signal is applied through electrodes to stimulate the anterior superior part (target site) of the patient's mastoid process, which is a spongy structure with multiple cavities and adjacent to the external auditory canal, thereby producing a local diathermy effect that achieves a therapeutic effect on inner ear diseases. The dominant frequency component can be a frequency peak or frequency lobe that includes the dominant frequency and has a certain bandwidth, or it can be a frequency band that includes the dominant frequency. The dominant frequency component can also be the fundamental frequency of a periodic signal, such as a square wave, triangular wave, or sine wave signal. The dominant frequency component is preferably greater than one of the following frequencies: 200kHz, 210kHz, 220kHz, 230kHz, 240kHz, 250kHz, 260kHz, 270kHz, 280kHz, 290kHz, 300kHz, 310kHz, 320kHz, 330kHz, 340kHz, 350kHz, 360kHz, 370kHz, 380kHz, 390kHz, 400kHz, 410kHz, 420kHz, 430kHz, 440kHz, or 450kHz; and preferably lower than one of the following frequencies: 600kHz, 590kHz, 580kHz, 570kHz, 560kHz, 550kHz, or 540kHz. Of course, other electrical stimulation signals with sufficiently high power (e.g., greater than 5W, greater than 6W, or greater than 7W (e.g., 7.5W)) within this frequency band can be considered to have a dominant frequency component within this frequency band and can be used for therapeutic effects, such as those applied by the device of the present invention. Of course, in order to optimize power concentration and signal utilization, it is recommended to concentrate the power of the electrical stimulation signal within the frequency band that produces the therapeutic effect.
[0014] In one embodiment variation, the dominant frequency component of the electrical stimulation signal is located between 450 kHz and 540 kHz, within the mid-frequency band. Specifically, the dominant frequency component of the electrical stimulation signal can be 495 kHz. Although ideally its bandwidth should be as narrow as possible, it is envisioned that it can also be as high as 90 kHz, thereby covering the frequency range between 450 kHz and 540 kHz, within which the best diathermy effect can be obtained to improve inner ear diseases. Therefore, the dominant frequency component is preferably greater than 450 kHz, 460 kHz, 470 kHz, 480 kHz, or 490 kHz, and preferably less than 540 kHz, 530 kHz, 520 kHz, 510 kHz, or 500 kHz.It is envisioned that the voltage of the electrical stimulation signal is 5 V and the current is 1.5 A, and the signal can even be generated by means of a portable battery that can be integrated into the device.
[0015] In one embodiment variation, in the direction of minimum distance between the first and second electrodes, the distance between the first and second electrodes is less than the distance between the ends of the first electrode and the distance between the ends of the second electrode, so that when these electrodes are attached to the patient's skin, the skin resistance between the first and second electrodes is low, and the transmission of the electrical stimulation signal is allowed and it is allowed to propagate toward the anterior superior part of the mastoid process. Specifically, the electrode spacing is 3 mm to 7 mm (typically 5 mm), the distance between the ends of each electrode is 10 mm to 15 mm (typically 14 mm), and the electrode width is 10 mm. These dimensions are suitable for arranging the electrodes on the anterior superior part of the mastoid process. Of course, if the support specification page 2 / 8 4 CN 121604991 A has only one electrode, the other electrode of this pair of electrodes will be placed in another area of the head, with the distance between the ends reaching 35 mm. However, it is anticipated that different electrode pairs can be used to treat each inner ear of a patient.
[0016] In one embodiment variant, the first and second electrodes are the same size, which prevents decompensation and avoids one electrode overheating or wearing out more than the other.
[0017] In one embodiment variant, the first and second electrodes are placed in a support that allows for quick and easy placement of the electrodes on the patient's mastoid process, even by the patient themselves, without the assistance of a medical professional. It is anticipated that the support can have different suitable shapes so that the one or more electrodes can be correctly positioned when placed on the patient's head. Of course, it is anticipated that the support can have different shapes that allow for the correct placement of the one or more electrodes on the patient. These shapes can be in the form of headphones, hearing aids, headsets, ear-hook headphones, glasses or temples, or helmets or hats, so that when the support is placed on the patient, the one or more electrodes transmitting electrical stimulation signals can be correctly positioned on the anterior superior part of the mastoid process of the ear to be treated.
[0018] In one embodiment variation, the first and second electrodes are symmetrically arranged on the support to achieve uniform transmission of the electrical stimulation signal.
[0019] In one embodiment variation, the first and second electrodes are arc-shaped to adapt to the shape of the patient's head, and may even embed into the skin of the patient's head. Thus, it is also anticipated that, for example, when the support is shaped like an earphone, the support is adapted to apply a certain force in a direction perpendicular to the electrodes, thereby improving the contact between the electrodes and the skin.Of course, it is anticipated that only one arcuate electrode may be provided, while the other electrode may be arranged on different parts of the patient's body. However, it is envisioned that, preferably, both electrodes are arcuate and positioned close to each other on the anterior superior part of the mastoid process.
[0020] In one embodiment variant, the first and second electrodes are parallel to each other, thereby achieving uniform transmission of the electrical stimulation signal.
[0021] In one embodiment variant, the support is adapted to be placed on the patient's head, and the support is configured such that when the support is placed on the patient's head, the patient's mastoid process is arranged adjacent to the first and second electrodes.
[0022] In one embodiment variant, the support includes earmuffs adapted to be placed on the patient's auricle. Of course, it is anticipated that the support may have two earmuffs, each earmuff being provided with a first and second electrode, each pair of electrodes being adapted to be adjacent to each of the two mastoid processes on both sides of the patient's head, and even the same generator and the same electrical stimulation signal may be used, which may form part of the same device or be remotely arranged, for example, connected to the control console of the device via a cable.
[0023] In one embodiment variant, the first and second electrodes are disposed in the periphery of the earmuff, thereby facilitating proper placement of the first and second electrodes when the earmuff is worn, and allowing the patient to clearly feel the first and second electrodes.
[0024] In one embodiment variant, the support includes an earmuff whose cross-section (e.g., its horizontal cross-section) defines a horseshoe arc, i.e., a C-shape, thereby forming an arc greater than 180 degrees that defines an internal region accommodating the auricle. Therefore, the earmuff is adapted to be positioned to cover and surround the patient's auricle, with at least one electrode disposed at one end of the earmuff such that when the patient wears the earmuff (which may be mounted on headphones), the electrode is located behind the patient's auricle, on the anterior superior part of the mastoid process.
[0025] In one embodiment variant, the support is further provided with a sound-generating device (e.g., a speaker) to enhance the therapeutic effect of the electrical stimulation signal on the mastoid process.
[0026] In one embodiment variant, the sound-emitting device is adapted to emit a sound with a blocking frequency band, which is the frequency band of the patient's tinnitus.
[0027] In one embodiment variant, the device includes a processing means adapted to block an audio signal frequency band, such that the blocking of the frequency band can be programmed by signal processing techniques (e.g., in a processor).
[0028] In one embodiment variant, the support is an earplug that allows one or more electrodes to be properly placed on a target site on the patient's mastoid process.
[0029] Thus, for example, by using the device of the present invention, a treatment method for treating inner ear diseases such as sensorineural inner ear disorders (e.g., tinnitus or hearing loss) can be implemented.This ear disease can be treated by applying an electrical stimulation signal to the anterior superior part of the mastoid process using electrodes. The electrical stimulation signal is, for example, the stimulation signal described above, for example, whose main frequency component is greater than 200 kHz and 600 kHz, more specifically, the middle frequency in that range, and more specifically, the electrical stimulation signal whose main frequency component is between 450 kHz and 540 kHz, and more specifically, the electrical stimulation signal whose main frequency component is 495 kHz.
[0030] To supplement the description herein and to better understand the features of the invention, this specification is accompanied by a set of drawings in which the following have been shown by way of example and non-limitation:
[0031] FIG1 shows a schematic diagram of the device of the invention;
[0032] FIG2 shows an example of an electrical stimulation signal for the device of the invention;
[0033] FIG3 shows the arrangement of the anterior superior part of the mastoid process on the skull of a patient, which is the target site of the device of the invention;
[0034] FIG4 shows a schematic diagram of the operation of the device of the invention on a patient;
[0035] FIG5 shows the first and second electrodes of the device of the invention in the relevant assembly position;
[0036] FIG6a and FIG6b show a first embodiment of the device of the invention placed on the head of a patient;
[0037] FIG7a and FIG7b show the device shown in FIG6a and FIG6b;
[0038] FIG7c shows a detailed cross-sectional view of the device shown in FIG7a and FIG7b;
[0039] FIG8a and FIG8b show a second embodiment of the device of the invention placed on the head of a patient; and
[0040] Figure 9 shows a third embodiment of the device according to the invention placed on the head of a patient. Detailed Description
[0041] The device 1 according to the invention has been used in an exploratory clinical study to evaluate the effect of applying high-frequency stimulation to the mastoid 101 of an adult patient with tinnitus and sensorineural hearing loss.
[0042] The device 1 also includes a generator 2 for generating an electrical stimulation signal 3 and electrodes 5a, 5b for applying the electrical stimulation signal 3 to the patient 100. To facilitate proper placement of the electrodes 5a, 5b on the mastoid 101 (i.e., the target area) of the patient 100, the electrodes 5a, 5b are configured to be properly positioned once placed on the head 102 of the patient 100 so that the electrical stimulation signal 3 can be applied to the anterior superior portion of the mastoid 101 of the patient 100.
[0043] In one embodiment variation, the electrical stimulation signal 3 is a high-frequency signal with a dominant frequency component greater than 200 kHz and less than 600 kHz. In the existing technology, it is not recommended to use this frequency range to treat hearing impairment because it is above the neuronal activation frequency, since known devices act directly on nerves to stimulate these nerves to treat hearing impairment such as tinnitus.
[0044] Surprisingly, however, a very localized diathermy effect has been observed by applying an electrical stimulation signal 3 of 5V and 1.5A to the mastoid process 101 at frequencies higher than 200kHz and lower than 600kHz (as described on page 4 / 8 of the manual, CN 121604991 A). This diathermy effect has been found to improve not only previously diagnosed tinnitus in patients but also sensorineural hearing loss. Of course, other voltages and currents are expected to produce the same effect.
[0045] The inclusion criteria for this study were: patients aged 18 to 70 years, without serious chronic diseases, not receiving drug treatment, with mild hearing loss, and without symptoms of vertigo or instability. In addition, participants needed to meet the following criteria: tinnitus lasting more than 6 months, tinnitus being non-pulsatile, gradually occurring, unrelated to traumatic events, a tinnitus volume score (1-100) between 40 and 60, and a Tinnitus Disability Scale (THI) score between 25 and 65. The study established an experimental group (receiving experimental treatment) and a placebo group, and subjects were randomly assigned.
[0046] During the study, an initial screening phase lasting up to 3 months was conducted, which was necessary to recruit participants for the study. Enrollment was expected to be patients who had received treatment and undergone hearing examinations and tests at the USD Hearing Center within the past six months.
[0047] The total duration of treatment in the study was 6 consecutive weeks, twice a week, approximately 40 minutes each time, using Device 1, approximately 15-20 minutes per ear, with at least 2 days and a maximum of 4 days between treatments.
[0048] Treatment ended at the end of the sixth week. Subsequently, two controlled assessments were planned, at 12 weeks and 6 months after the start of the study.
[0049] The results showed that, compared to the placebo group, the experimental group had significant improvements in the Tinnitus Disability Scale (THI) and minimum masking level (≥5 dB) at the end of treatment. Furthermore, although the study was initially designed specifically to investigate tinnitus, it was found that many patients experienced an improvement of more than 10 dB HL in pure-tone hearing threshold (PTA) in their treated ear within three months after the end of treatment.
[0050] Based on this study, these results may be related to diathermy effects in inner ear metabolism and homeostasis, meaning they are expected to be applicable to other inner ear diseases, such as for the treatment of patients with Meniere's disease.
[0051] This study has been conducted using device 1 according to the invention, embodiments of which will be described below. Of course, other embodiments of device 1 not described below are also expected to provide the desired therapeutic effects.
[0052] Figure 1 shows a schematic diagram of device 1 for treating sensorineural disorders of the inner ear (e.g., tinnitus or hearing loss) in patient 100.As shown in the figure, the device 1 includes a generator 2 for generating an electrical stimulation signal 3, and electrodes 5a and 5b for applying the electrical stimulation signal 3 to a patient 100. Specifically, electrodes 5a and 5b are configured to apply the electrical stimulation signal 3 to the anterior superior portion of the mastoid process 101 of the patient 100. The device 1 includes a first electrode 5a and a second electrode 5b. Placing at least one electrode 5a and 5b on the patient 100 is essential to the present invention, as will be detailed below. Of course, the generator 2 can be located externally to the device 1, for example in a console, peripheral device, or remote control, and the electrical stimulation signal 3 can be transmitted directly to the electrodes 5a and 5b of the device 1, for example, via a cable.
[0053] In the schematic diagram shown, the device 1 is also provided with a sound-emitting device 9 adapted to emit a sound with a blocking frequency band, and the device 1 is provided with a processing device 11 adapted to block a certain frequency band of the audio signal 12. These sound-emitting devices 9 are optional, and their inclusion has been shown to further enhance the therapeutic effect of the applied electrical stimulation signal 3. Of course, the processing device can also be located outside the device 1, for example in a console, peripheral device or remote control, and the audio signal 12 can be transmitted directly to the sound-generating device 9 of the device 1, for example via a cable. It is anticipated that a single cable can be used to power the device 1, transmit the audio signal 12 (optionally processed audio signal), and send one or more of other data (e.g., start instructions, stop instructions for transmitting the status record of the device 1).
[0054] FIG2 shows an electrical stimulation signal 3 suitable for use in the device 1 of the present invention and used in this study. It can be seen that FIG2 shows the spectrum of the electrical stimulation signal 3 suitable for use in the device 1 of the present invention, specifically the power spectrum or the power spectral density on page 5 / 8 of the specification, CN 121604991 A. It can be seen from this that the electrical stimulation signal 3 has a dominant frequency component greater than 200 kHz and less than 600 kHz, specifically, its dominant frequency is between 450 kHz and 540 kHz, and its peak is about 495 kHz. The signal may also have other dominant frequency components (e.g., frequency peaks) in other ranges. As can be seen, in the electrostimulation signal 3 shown with its dominant frequency bandwidth, the other frequency components of the signal are sufficiently attenuated and thus considered noise. Therefore, the electrostimulation signal 3 is expected to be a fundamental sinusoidal signal with a fundamental frequency of approximately 495 kHz, although other forms of the electrostimulation signal 3 with the same dominant or fundamental frequency are also envisioned, such as square wave or sawtooth wave signals, which have other frequency components but keep the fundamental frequency within the previously specified range. It can be seen that the electrostimulation signal 3 is expressed in dBm, which means that its scale is logarithmic, with a peak power much greater than 495 kHz (which will be slightly less than 40 dBm), while the power of the remaining frequencies is much lower.As can be seen, given that the electrical stimulation signal 3 in this example is a 5V and 1.5A signal with a power of 7.5W, equivalent to 38.75dBm, which is approximately the peak value at 495kHz, this means that most of the power of the signal is concentrated around this frequency. Specifically, the power is concentrated at the peak frequency and may be within a bandwidth of up to 90kHz, i.e., concentrated between 450kHz and 540kHz, where the power drops by 30dBm. Outside this bandwidth, the power of the signal 3 shown is very low, comparable to noise. To obtain a therapeutic effect when applied to the anterior superior part of the mastoid 101, the possibility of using another type of electrical stimulation signal 3 with other frequencies cannot be ruled out, particularly other signals with a dominant frequency in or close to the mid-frequency band, such as signals with a dominant frequency between 200kHz and 600kHz. Thus, the possibility of using lower frequencies and frequencies above 100kHz to produce therapeutic effects cannot be ruled out.
[0055] Figure 3 shows the anterior superior portion of the mastoid 101 of patient 100, on which at least one electrode 5a, 5b of the device 1 of the present invention must be placed. This anterior superior portion is the target site for the electrical stimulation signal 3, which circulates between the two electrodes 5a, 5b, such that the electrical stimulation signal 3 emitted from at least one electrode 5a, 5b can reach the anterior superior portion of the mastoid 101 of patient 100. When at least one electrode 5a, 5b is placed on the anterior superior portion of the mastoid 101, the electrical stimulation signal 3 emitted from at least one electrode 5a, 5b can reach the anterior superior portion of the mastoid 101 of patient 100. Figure 3 also shows the auricle 103 of patient 100, thus showing that the anterior superior portion of the mastoid 101 is covered by the auricle 103, such that the device 1 must be configured to contact the posterior portion of the auricle 103 in order to arrange one or more electrodes 5a, 5b on the anterior superior portion of the target mastoid 101 so that the transmission of the electrical stimulation signal 3 can stimulate the target area. The target area is the middle part of the mastoid process on the skin, located behind the insertion line of the auricle 103. It can be regarded as the anterior superior quadrant of the mastoid process 101, located in the area adjacent to the external auditory canal 105, and is usually located on the extension line of the horizontal imaginary line 104 passing through the external auditory canal. Therefore, when at least one electrode 5a, 5b is placed on the patient 100, it is positioned on the anterior superior part of the mastoid process 101 of the patient 100, so that the electrical stimulation signal 3 emitted from at least one electrode 5a, 5b can reach the anterior superior part of the mastoid process 101 of the patient 100, thereby stimulating it to achieve a therapeutic effect.
[0056] Figure 4 shows a schematic diagram of the electrodes 5a, 5b used to transmit the electrical stimulation signal 3 of the device 1 when applied to the patient 100. It can be seen that the electrodes 5a, 5b include a first electrode 5a and a second electrode 5b arranged on the head 102 of the patient 100.Electrodes 5a and 5b are mounted on a support 6, which facilitates the application of electrodes 5a and 5b to the anterior upper part of the mastoid 101, the site where the electrical stimulation signal 3 is to be applied. As shown, the electrical stimulation signal 3 is conducted between electrodes 5a and 5b through the patient 100, and the electrodes 5a and 5b propagate the electrical stimulation signal 3 by covering the mastoid 101 of the patient 100. It is anticipated that the electrical stimulation signal 3 may also be propagated in the form of radiation, for example, partial radiation, depending on the resistance of the patient 100 between electrodes 5a and 5b, since the connection between electrodes 5a and 5b through the patient 100 can be modeled as a parallel resistance and capacitance.
[0057] Figure 5 shows an example of electrodes 5a and 5b for use in the device 1 of the present invention. It can be seen that electrodes 5a and 5b are arc-shaped to facilitate contact with the skin of the patient 100. It can also be seen that in the direction where the distance between the first electrode 5a and the second electrode 5b is the smallest, the interval distance d1 between the first electrode 5a and the second electrode 5b is smaller than the distance d2 between the two ends of the first electrode 5a and the distance d2 between the two ends of the second electrode 5b. In this case, since the electrodes 5a and 5b are the same size and parallel to each other, the distance d2 between the two ends of each electrode 5a and 5b is equal. It can be seen that in this case, the electrodes 5a and 5b made of metal are attached to the dielectric base 15 mounted in the support member 6 of the device 1, so that the electrodes 5a and 5b are disposed on the support member 6.
[0058] Figures 6a and 6b show a first embodiment of the device 1 according to the invention, which includes a first electrode 5a and a second electrode 5b. It can be seen that the first electrode 5a and the second electrode 5b are the same size and parallel to each other. In the direction where the distance between the first electrode 5a and the second electrode 5b is the smallest, the distance between the first electrode 5a and the second electrode 5b is smaller than the distance between the two ends of the first electrode 5a and the distance between the two ends of the second electrode 5b. The two electrodes are arranged in the earmuff 10 provided with the pad 8.
[0059] The first electrode 5a and the second electrode 5b are placed in the support 6, which in this example takes the form of an earphone 7 (also called a headset or headphone receiver), which facilitates the placement of the device 1 on the head 102 of the patient 100, such that the electrodes 5a and 5b are configured to apply the electrical stimulation signal 3 to the anterior upper part of the mastoid process 101 of the patient 100, that is, they are properly placed on the skin behind the auricle 103 of the head 102 of the patient 100. During the treatment of inner ear diseases, electrodes 5a and 5b apply an electrical stimulation signal 3 with a main frequency component greater than 200 kHz and less than 600 kHz, as described above, preferably a signal with a main frequency located in the mid-frequency band.
[0060] The device 1 is expected to be equipped with a timer to limit the application time of the electrical stimulation signal 3, preferably allowing 15 or 20 minutes of use per ear, and the electrical stimulation signal 3 can only be applied to the ear again after an interval of at least 24 hours.
[0061] It can be seen that the support 6 includes an earmuff 10 adapted to be placed on and around the auricle 103 of the patient 100, and has padding 8 to provide more comfortable fixation. The first electrode 5a and the second electrode 5b are arranged on the periphery of the earmuff 10, which allows the electrodes 5a, 5b to be conveniently placed behind the auricle 103 of the patient 100, on the anterior superior part of the mastoid process 101. Since the device 1 has two earmuffs 10, a pair of electrodes 5a, 5b can be placed in each earmuff 10. Of course, the treatment of inner ear diseases is only performed in the ear affected by, for example, tinnitus or hearing loss. The treatment is performed by applying an electrical stimulation signal 3 via electrodes 5a and 5b, and optionally, tinnitus is treated by emitting a sound with a blocking frequency band via a sound-emitting device 9, the blocking frequency band being the frequency band corresponding to the tinnitus frequency in the ear of the patient 100, which has been determined in advance by known techniques.
[0062] In this case, given that the support 6 is an earphone 7, the sound-emitting device 9 incorporated in the earmuff 10 can also be used to emit sound to assist in the treatment of the aforementioned inner ear disease. Of course, it is expected that the earphone 7 is provided with an adjustable headband 13 that connects the two earmuffs 10 above the head 102 of the patient 100, so that the patient 100 can adjust the device 1 so that they are properly set to surround and fit the auricle 103, and the electrodes 5a and 5b are thus automatically and correctly placed on each mastoid 101, thereby applying a certain pressure to the head 102 to ensure contact of the electrodes 5a and 5b. Of course, the earmuff 10 may not have a headband 13, for example, it may be worn directly on the patient's auricle 103, or it may have other fixing devices to ensure proper wearing of the earmuff 10.
[0063] Figures 7a and 7b show more detailed views of a first embodiment of the device 1, which is in the form of headphones 7, wherein the support 6 includes an earmuff 10 adapted to be placed on the auricle 103 of the patient 100, and the first electrode 5a and the second electrode 5b are symmetrically arranged in an arc shape on the periphery of the earmuff 10 and are parallel to each other. It can also be seen that, in order to make the device 1 self-supporting, a power supply (e.g., a battery) is arranged inside the earmuff 10, and the earmuff 10 is provided with a charging port 14, for example, a USB port suitable for connecting a power cord and transmitting data. It is also expected that the device 1 may be directly connected to a power source, which in this example is provided with a power cord. When the device 1 is self-supporting, it allows the patient 100 greater freedom of movement during its use, but it is also expected that it may be connected to a power source, for example, via a cable.It is anticipated that the cables can directly connect electrodes 5a and 5b to the generator 2 of the electrical stimulation signal 3, which can be arranged independently, for example, in a console connected to the headphones 7. In this case, the device 1 is formed by the headphones and the console. The console can also directly transmit sound, appropriately processed as described on pages 7 / 8 of the specification (CN 121604991 A), to the sound-generating device 9. Similarly, it is anticipated that when the device 1 is self-supporting and uses the sound-generating device 9, the device 1 also includes a radio signal receiving device that enables the radio signal to be received from a remote transmitter and converted into an audio signal 12 to be emitted by the sound-generating device 9. These radio signal receivers can be Bluetooth audio receivers or even frequency modulation radio receivers. In this case, it is anticipated that the audio signal 12 can be pre-processed (e.g., with a blocking band) before transmission, or can be processed after reception. It is also anticipated that when the device 1 is self-supporting and included, the audio signal processing device 11 generates a predetermined audio signal 12, such as a white noise signal with a blocking band. The device 1 is expected to have a control device capable of indicating the frequency to be blocked.
[0064] FIG7c shows a cross-section C visible in FIG7b to illustrate that the support 6 includes an earmuff 10 whose cross-section C defines a horseshoe arc, i.e., a C-shape, thereby forming an arc greater than 180 degrees to form an inner region 16 (e.g., 5 cm x 7 cm) with an overhang of at least 1 cm at the edge for receiving and securing the auricle 103. Thus, the earmuff 10 is adapted to be positioned to cover and surround the auricle 103. In this example, a first electrode 5a is disposed at one end of the earmuff 10 such that the first electrode 5a mounted on the base 15 is positioned behind the auricle 103 of the patient 100, on the anterior superior portion of the mastoid process 101. A flexible pad 8 is also provided at the end of the earmuff 10 to facilitate receiving the auricle 103 in the inner region 16. Therefore, when the patient wears the earmuff 10 (which can be mounted on the earphone 7), the electrodes 5a and 5b can be automatically positioned for treatment without medical intervention. This means the patient 100 can perform the treatment themselves, for example, at home. Of course, the earmuff 10 may have a single electrode 5a or 5b, with the other electrode positioned elsewhere on the patient 100's body. However, for more effective treatment, it is recommended that both electrodes 5a and 5b be positioned on the upper front part of the mastoid process 101 to minimize contact with the hair. The earmuff 10 also includes a sound-generating device 9 (speaker) which can be used to assist in the treatment.
[0065] Figures 8a and 8b show a second embodiment of the device 1 according to the invention, wherein electrodes 5a, 5b are mounted on a support 6 shaped like an eyeglass frame, and the one or more electrodes 5a, 5b are mounted on the curved ends of the temples such that they are positioned behind the auricle 103 and on the anterior upper part of the mastoid process 101.
[0066] Figure 9 shows a third embodiment of the device 1 according to the invention, wherein electrodes 5a, 5b are mounted on a support 6 shaped like a helmet or hat, the helmet or hat being adapted to be positioned behind the auricle 103, and the portion of the helmet or hat adapted to be positioned behind the auricle 103 is provided with one or more electrodes 5a, 5b such that they are positioned behind the auricle 103 and on the anterior upper part of the mastoid process 101. Instruction Manual Page 8 / 8, 10 CN 121604991 A, Figure 1, Figure 2; Instruction Manual Appendix Page 1 / 8, 11 CN 121604991 A, Figure 3, Figure 4; Instruction Manual Appendix Page 2 / 8, 12 CN 121604991 A, Figure 5; Instruction Manual Appendix Page 3 / 8, 13 CN 121604991 A, Figure 6a; Instruction Manual Appendix Page 4 / 8, 14 CN 121604991 A, Figure 6b, Figure 7a; Instruction Manual Appendix Page 5 / 8, 15 CN 121604991 A, Figure 7b, Figure 7c; Instruction Manual Appendix Page 6 / 8, 16 CN 121604991 A, Figure 8a, Figure 8b; Instruction Manual Appendix Page 7 / 8, 17 CN 121604991 A, Figure 9; Instruction Manual Appendix Page 8 / 8, 18 CN 121604991 A 1. A device (1) for treating an inner ear disease such as tinnitus or hearing loss in a patient (100), the device comprising at least one electrode (5a, 5b) adapted to transmit an electrical stimulation signal (3) to the patient (100), wherein the at least one electrode (5a, 5b) is mounted on a support (6) configured such that when the support is placed on the patient (100), the at least one electrode (5a, 5b) is positioned on the anterior superior portion of the mastoid process (101) of the patient (100), such that the electrical stimulation signal (3) transmitted from the at least one electrode (5a, 5b) reaches the anterior superior portion of the mastoid process (101) of the patient (100), characterized in that the dominant frequency component of the electrical stimulation signal (3) is greater than 200 kHz and less than 600 kHz. 2. The device according to the preceding claim, characterized in that the dominant frequency component of the electrical stimulation signal (3) is between 450 kHz and 540 kHz.3. The device according to the preceding claim, characterized in that the dominant frequency component of the electrical stimulation signal (3) is 495 kHz. 4. The device according to any one of the preceding claims, characterized in that the device comprises a first electrode (5a) and a second electrode (5b) mounted on the support (6), the support being configured such that when the electrodes (5a, 5b) are placed on the patient (100), they are positioned on the anterior superior portion of the mastoid process (101) of the patient (100). 5. The device (1) according to the preceding claim, characterized in that, in the direction of minimum distance between the first electrode (5a) and the second electrode (5b), the spacing distance (d1) between the first electrode (5a) and the second electrode (5b) is less than the distance (d2) between the two ends of the first electrode (5a) and the distance (d2) between the two ends of the second electrode (5b). 6. The device (1) according to any one of claims 4 to 5, characterized in that the first electrode (5a) and the second electrode (5b) are of the same size. 7. The device (1) according to any one of claims 4 to 6, characterized in that the first electrode (5a) and the second electrode (5b) are symmetrically arranged on the support (6). 8. The device (1) according to any one of claims 4 to 7, characterized in that the first electrode (5a) and the second electrode (5b) are arc-shaped. 9. The device (1) according to any one of claims 4 to 8, characterized in that the first electrode (5a) and the second electrode (5b) are parallel to each other. 10. The device (1) according to any one of the preceding claims, characterized in that the support (6) includes an earmuff (10) having a cross-section (C) defining a horseshoe arc shape, the earmuff (10) being adapted to be positioned to cover and surround the auricle (103) of the patient (100), and the at least one electrode (5a, 5b) being disposed at one end of the earmuff (10). 11. The device (1) according to any one of the preceding claims, characterized in that the device further includes a sound-generating device (9). 12. The apparatus (1) according to the preceding claim, characterized in that the sound-emitting device (9) is adapted to emit sound having a blocking frequency band. 13. The apparatus (1) according to the preceding claim, characterized in that the apparatus includes a processing device (11) adapted to block the frequency band of an audio signal (12). 14. The apparatus (1) according to any one of the preceding claims, characterized in that the support member (6) is an earphone (7). Claims amended under Article 19 of the Treaty, page 1 / 1, CN 121604991 A.
Claims
1. A device (1) for treating an inner ear disease such as tinnitus or hearing loss in a patient (100), the device comprising at least one electrode (5a, 5b) adapted to transmit an electrical stimulation signal (3) to the patient (100), characterized in that, The at least one electrode (5a, 5b) is mounted on a support (6) configured such that when the support is placed on the patient (100), the at least one electrode (5a, 5b) is positioned on the anterior superior portion of the mastoid process (101) of the patient (100), such that the electrical stimulation signal (3) transmitted from the at least one electrode (5a, 5b) reaches the anterior superior portion of the mastoid process (101) of the patient (100).
2. The apparatus according to the preceding claim, characterized in that, The main frequency component of the electrical stimulation signal (3) is greater than 200kHz and less than 600kHz.
3. The apparatus according to the preceding claim, characterized in that, The dominant frequency component of the electrical stimulation signal (3) is between 450 kHz and 540 kHz.
4. The apparatus according to the preceding claim, characterized in that, The dominant frequency component of the electrical stimulation signal (3) is 495kHz.
5. The apparatus according to any one of the preceding claims, characterized in that, The device includes a first electrode (5a) and a second electrode (5b) mounted on the support (6), the support being configured such that when the electrodes (5a, 5b) are placed on the patient (100), they are positioned on the anterior superior part of the mastoid process (101) of the patient (100).
6. The apparatus (1) according to the preceding claim, characterized in that, In the direction where the distance between the first electrode (5a) and the second electrode (5b) is the smallest, the interval distance (d1) between the first electrode (5a) and the second electrode (5b) is smaller than the distance (d2) between the two ends of the first electrode (5a) and the distance (d2) between the two ends of the second electrode (5b).
7. The apparatus (1) according to any one of claims 5 to 6, characterized in that, The first electrode (5a) and the second electrode (5b) are the same size.
8. The apparatus (1) according to any one of claims 5 to 7, characterized in that, The first electrode (5a) and the second electrode (5b) are symmetrically arranged on the support (6).
9. The apparatus (1) according to any one of claims 5 to 8, characterized in that, The first electrode (5a) and the second electrode (5b) are arc-shaped.
10. The apparatus (1) according to any one of claims 5 to 9, characterized in that, The first electrode (5a) and the second electrode (5b) are parallel to each other.
11. The apparatus (1) according to any one of the preceding claims, characterized in that, The support (6) includes an earmuff (10) whose cross-section (C) defines a horseshoe arc shape, the earmuff (10) being adapted to be positioned to cover and surround the auricle (103) of the patient (100), and the at least one electrode (5a, 5b) being disposed at one end of the earmuff (10).
12. The apparatus (1) according to any one of the preceding claims, characterized in that, The device is also equipped with a sound-generating device (9).
13. The apparatus (1) according to the preceding claim, characterized in that, The sound-generating device (9) is adapted to emit sound with a blocking frequency band.
14. The apparatus (1) according to the preceding claim, characterized in that, The device includes a processing device (11) suitable for blocking the frequency band of the audio signal (12).
15. The apparatus (1) according to any one of the preceding claims, characterized in that, The support member (6) is an earphone (7).
